BamSEC and AlphaSense Join Forces
Learn More

Tempest Therapeutics Inc.

NASDAQ: TPST    
Share price (1/8/25): $0.99    
Market cap (1/8/25): $43.0 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.1
from 8-K 3 pages Amendment No. 2 to Rights Agreement
12/34/56
EX-4.1
from 8-K 4 pages Amendment No. 1 to Rights Agreement
12/34/56
EX-4.4
from S-3 55 pages Tempest Therapeutics, Inc. Issuer and [Trustee], Trustee Indenture Dated as of [•], 20__ Debt Securities
12/34/56
EX-4.1
from 10-K 9 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.1
from 8-K 62 pages Rights Agreement October 10, 2023
12/34/56
EX-4.1
from 8-K 16 pages Pre-Funded Common Stock Purchase Warrant Tempest Therapeutics, Inc
12/34/56
EX-4.1
from 10-K/A 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.4
from S-3 39 pages Tempest Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [●], 20[●] Debt Securities
12/34/56
EX-4.2
from S-4/A 10 pages Warrant to Purchase Stock [___]
12/34/56
EX-4.6
from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.9
from S-3 20 pages Millendo Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Millendo Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.8
from S-3 22 pages Millendo Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Millendo Therapeutics, Inc. Form of Preferred Stock Warrant Agreement
12/34/56
EX-4.7
from S-3 21 pages Millendo Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Millendo Therapeutics, Inc. Form of Common Stock Warrant Agreement
12/34/56
EX-4.5
from S-3 49 pages Millendo Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [·], 20 Debt Securities
12/34/56
EX-4.10
from S-3/A 4 pages Ovascience, Inc. First Amendment to Stock Purchase Agreement
12/34/56
EX-4.9
from S-3 3 pages Millendo Therapeutics Sas First Amendment to Shareholders and Option Agreement
12/34/56
EX-4.8
from S-3 17 pages Shareholders and Option Agreement of Alizé Pharma Sas December 19, 2017 Alizé Pharma Sas Shareholders and Option Agreement
12/34/56
EX-4.7
from S-3 11 pages Millendo Therapeutics, Inc. First Amendment to Second Amended and Restated Investor Rights Agreement
12/34/56
EX-4.6
from S-3 46 pages Millendo Therapeutics, Inc. Second Amended and Restated Investor Rights Agreement
12/34/56
EX-4.8
from S-3 39 pages Ovascience, Inc. Issuer and [ ] Trustee Indenture Dated as of [ ] Subordinated Debt Securities
12/34/56